These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9108963)

  • 1. In vivo evidence of HIV-1 productive infection in cerebrospinal fluid of patients with HIV-1 encephalopathy.
    Di Stefano M; Monno L; Ramon Fiore J; Angarano G
    AIDS; 1997 Apr; 11(5):698-9. PubMed ID: 9108963
    [No Abstract]   [Full Text] [Related]  

  • 2. Cerebrospinal fluid HIV load in diverse clinical circumstances.
    Jenny-Avital ER; Hoffman J; Katz M; Leider J; Apfelroth S
    Clin Infect Dis; 2008 Jun; 46(12):1938-40; author reply 1940-1. PubMed ID: 18540816
    [No Abstract]   [Full Text] [Related]  

  • 3. Viral load in HIV-associated dementia.
    Glass JD; Wesselingh SL
    Ann Neurol; 1998 Jul; 44(1):150-1. PubMed ID: 9667609
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical importance of the quantification of HIV-1 RNA in cerebrospinal fluid for the diagnosis of HIV encephalitis].
    Bossi P; Dupré S; Dupin N; Coutellier A; Bricaire F; Lubetzki C; Katlama C; Calvez V
    Pathol Biol (Paris); 1998 Jun; 46(6):423-5. PubMed ID: 9769875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 RNA levels in cerebrospinal fluid and plasma correlate with AIDS dementia.
    Hengge UR; Brockmeyer NH; Esser S; Maschke M; Goos M
    AIDS; 1998 May; 12(7):818-20. PubMed ID: 9619817
    [No Abstract]   [Full Text] [Related]  

  • 6. Cerebrospinal fluid HIV-1 infection usually responds well to antiretroviral treatment.
    Mellgren A; Antinori A; Cinque P; Price RW; Eggers C; Hagberg L; Gisslén M
    Antivir Ther; 2005; 10(6):701-7. PubMed ID: 16218168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Undetectable tumor necrosis factor-alpha in spinal fluid from HIV-1-infected patients.
    Shaskan EG; Thompson RM; Price RW
    Ann Neurol; 1992 Jun; 31(6):687-9. PubMed ID: 1514782
    [No Abstract]   [Full Text] [Related]  

  • 8. Intrathecal reactivity for myelin components precedes development of neurological symptoms in AIDS patients.
    Silva AA; Câmara V; Quirico-Santos T
    Arch Med Res; 1997; 28(3):391-6. PubMed ID: 9291637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV in the brain: an interview with Dr. Michael Wool, UCLA researcher.
    Wool M
    Posit Dir News; 1998 Jan; 10(1):18-24. PubMed ID: 11365052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo evidence of HIV-1 productive infection in cerebrospinal fluid of patients with HIV-1 encephalitis.
    Di Stefano M; Monno L; Fiore JR; Angarano G
    AIDS; 1997 Jan; 11(1):133-5. PubMed ID: 9110095
    [No Abstract]   [Full Text] [Related]  

  • 11. Amplification of human immunodeficiency virus provirus from cerebrospinal fluid: results of long-term clinical follow-up.
    Shaunak S; Albright RE; Bartlett JA
    J Infect Dis; 1991 Oct; 164(4):818. PubMed ID: 1894945
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of cerebrospinal fluid uPA, PAI-1, and soluble uPAR levels in HIV-infected patients.
    Sporer B; Koedel U; Popp B; Paul R; Pfister HW
    J Neuroimmunol; 2005 Jun; 163(1-2):190-4. PubMed ID: 15885322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain.
    McArthur JC; McClernon DR; Cronin MF; Nance-Sproson TE; Saah AJ; St Clair M; Lanier ER
    Ann Neurol; 1997 Nov; 42(5):689-98. PubMed ID: 9392567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the glass three-quarters full or one-quarter empty?
    McArthur JC; Letendre SL
    J Infect Dis; 2006 Dec; 194(12):1628-31. PubMed ID: 17109332
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurobehavioral manifestations and sequelae of HIV and other infections.
    Pontrelli L; Pavlakis S; Krilov LR
    Child Adolesc Psychiatr Clin N Am; 1999 Oct; 8(4):869-78. PubMed ID: 10553208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 RNA levels in the cerebrospinal fluid may increase owing to damage to the blood-brain barrier.
    Burger DM; Boucher CA; Meenhorst PL; Kraayeveld CL; Portegies P; Mulder JW; Hoetelmans RM; Beijnen JH
    Antivir Ther; 1997 Apr; 2(2):113-7. PubMed ID: 11322275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raltegravir penetration in the cerebrospinal fluid of HIV-positive patients.
    Calcagno A; Bonora S; Bertucci R; Lucchini A; D'Avolio A; Di Perri G
    AIDS; 2010 Mar; 24(6):931-2. PubMed ID: 20234194
    [No Abstract]   [Full Text] [Related]  

  • 18. Feasibility assessment of cerebrospinal fluid from HIV-1-infected children for HIV proviral DNA and monocyte chemoattractant protein 1 alleles.
    Shiramizu B; Lau E; Tamamoto A; Uniatowski J; Troelstrup D
    J Investig Med; 2006 Dec; 54(8):468-72. PubMed ID: 17169271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in AIDS dementia complex.
    Candito M; Durant J; Gurle V; Chambon P; Dellamonica P
    AIDS; 1995 Sep; 9(9):1100-1. PubMed ID: 8527086
    [No Abstract]   [Full Text] [Related]  

  • 20. Cerebrospinal fluid concentration of fibronectin in patients with HIV-1 infection and central nervous system disorders.
    Torre D; Zeroli C; Ferrario G; Bonetta G; Fiori GP; Martegani R
    J Clin Pathol; 1993 Nov; 46(11):1039-41. PubMed ID: 8254093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.